APA

Iravani A., Osman M. M., Weppler A. M., Wallace R., Galligan A., Lasocki A., Hunter M. O., Akhurst T., Hofman M. S., Lau P. K. H., Kee D., Au-Yeung G., Sandhu S. & Hicks R. J. (20210514). FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. : European journal of nuclear medicine and molecular imaging.

Chicago

Iravani Amir, Osman Medhat M, Weppler Alison M, Wallace Roslyn, Galligan Anna, Lasocki Arian, Hunter Morgan O, Akhurst Tim, Hofman Michael S, Lau Peter K H, Kee Damien, Au-Yeung George, Sandhu Shahneen and Hicks Rodney J. 20210514. FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. : European journal of nuclear medicine and molecular imaging.

Harvard

Iravani A., Osman M. M., Weppler A. M., Wallace R., Galligan A., Lasocki A., Hunter M. O., Akhurst T., Hofman M. S., Lau P. K. H., Kee D., Au-Yeung G., Sandhu S. and Hicks R. J. (20210514). FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. : European journal of nuclear medicine and molecular imaging.

MLA

Iravani Amir, Osman Medhat M, Weppler Alison M, Wallace Roslyn, Galligan Anna, Lasocki Arian, Hunter Morgan O, Akhurst Tim, Hofman Michael S, Lau Peter K H, Kee Damien, Au-Yeung George, Sandhu Shahneen and Hicks Rodney J. FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. : European journal of nuclear medicine and molecular imaging. 20210514.